NYSE · Medical - Care Facilities

EHC (EHC) Stock

$122.05 +1.53% NYSE: EHC Healthcare

Valuation

MetricValue
Price$122.05
Market Cap$12.11B
P/E Ratio18.97
P/B Ratio4.28
P/S Ratio1.71
EPS (TTM)$5.54
52-Week High$127.99
52-Week Low$92.77
Dividend Yield0.71%

Financials & Margins

MetricValue
ROE23.22%
ROA7.98%
ROCE32.14%
Gross Margin17.74%
Operating Margin17.74%
Net Margin10.04%
Debt/Equity1.11
Current Ratio1.08

Annual Financials (USD)

Metric20212022202320242025
Revenue$4.0B$4.3B$4.8B$5.4B$5.9B
Operating Profit$659.0M$630.0M$1.7B$865.0M$1.1B
Net Profit$412.0M$271.0M$352.0M$456.0M$566.0M
EPS$4.11$2.70$3.47$4.46$5.54
Op Margin16.4%14.5%35.9%16.1%17.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$6.9B$5.6B$6.1B$6.5B$7.1B
Total Liabilities$4.5B$3.8B$3.8B$3.7B$3.8B
Cash$49.0M$22.0M$104.0M$85.0M$103.0M
Borrowings$3.5B$3.0B$2.9B$2.7B$2.7B

Latest News

EHC: Lowering target price to $120.00 Argus Research · Jul 15, 2026 Encompass Health announces date of 2026 second quarter earnings call PR Newswire · Jul 9, 2026 Encompass Health (EHC) Stock May Be A Bargain Following Growing Investor Interest Simply Wall St. · Jul 9, 2026 Encompass Health (EHC) Could Be 12% Overvalued Following Branford Facility Progress Simply Wall St. · Jul 8, 2026 1 Cash-Producing Stock Worth Your Attention and 2 We Question StockStory · Jul 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$716.0M$706.0M$851.0M$1.0B$1.2B
Investing Cash Flow$-1.2B$-1.2B$-1.2B$-1.3B$-1.5B
Financing Cash Flow$-69.0M$452.0M$-53.0M$-26.0M$-333.0M
Net Cash Flow$-191.0M$-67.0M$51.0M$19.0M$-20.0M
Free Cash Flow$165.0M$122.0M$268.0M$360.0M$439.0M

About EHC

EHC is led by CEO Mark J. Tarr, employs 42,300 people, headquartered in Birmingham, US, publicly traded since 1986.

EHC stock trades at $122.05 with a market capitalization of $12.11B. The stock is valued at a price-to-earnings (P/E) ratio of 18.97, price-to-book of 4.28, price-to-sales of 1.71. Over the past 52 weeks the stock has ranged between $92.77 and $127.99, and currently trades 4.6% below its 52-week high. It pays a dividend yielding 0.71%.

On profitability, EHC generates a return on equity (ROE) of 23.22% — well above the market average, a sign of a high-quality business, return on capital employed of 32.14%, an operating margin of 17.74%, a net profit margin of 10.04%.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides